Full Text
RWD285 COST-UTILITY ANALYSIS OF ECULIZUMAB FOR ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS) IN THAILAND

Abstract

Authors

Sutinee Soopairin Parnnaphat Luksameesate Chanthawat Patikorn Suthira Taychakhoonavudh

Back to Volume 49, Supplemental S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×